We have created a technology platform that allows physicians the opportunity to integrate autologous PRP (Platelet-rich Plasma) and BMCC (Bone Marrow Cell Concentrate) biologic preparations into their practice.
Learn MoreThe use of a patient’s own biologic preparation complements the natural healing process present in patients but is dependent on a variety of components.
Learn MoreNumerous reports on potential applications for PRP and BMCC suggest that autologous PRP and BMCC preparations are considered to support a patient’s natural healing processes.
Learn MoreFounder and Chief Executive Officer
Greyledge operations are currently being led by company Founder and CEO – David Karli. He is responsible for all aspects of company development, including the integration of a strong team of professionals to support Greyledge’s innovative approach to regenerative medicine.
Director of Training and Development
In his position as Director of Training & Development, his duties include all aspects of laboratory operations, training and providing other support to maintain Greyledge’s commitment to quality. Tim is a key element in the development and launch of new Laboratories.